Trials

CTD Holdings Clinical Trial

CTD Holding’s Trappsol Cyclodextrin trial is currently enrolling in two trial sites: Oakland, US and Manchester, UK. The Phase 1 trial in the US requires patients to be 18+ and is looking to recruit approximately 12 patients for a research study lasting up to 20 weeks. The Phase 1/2 trial in the UK is also looking…

So if you want to help make a difference to a rare disease, and want 99% of the money you raise to go to making that difference, why not support us.

Find Out More

Niemann-Pick Research Foundation,
44 Ledborough Lane, Beaconsfield, Buckinghamshire, HP9 2DD.
Registered charity number 1141036

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

More information about our Cookie Policy